ROBLOX CORP -CLASS A (RBLX) Fundamental Analysis & Valuation

NYSE:RBLX • US7710491033

Current stock price

45.13 USD
-10.13 (-18.33%)
At close:
45.21 USD
+0.08 (+0.18%)
After Hours:

This RBLX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. RBLX Profitability Analysis

1.1 Basic Checks

  • In the past year RBLX has reported negative net income.
  • RBLX had a positive operating cash flow in the past year.
  • RBLX had negative earnings in each of the past 5 years.
  • RBLX had a positive operating cash flow in each of the past 5 years.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • With a Return On Assets value of -11.14%, RBLX is not doing good in the industry: 63.29% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -269.99%, RBLX is doing worse than 75.95% of the companies in the same industry.
Industry RankSector Rank
ROA -11.14%
ROE -269.99%
ROIC N/A
ROA(3y)-14.29%
ROA(5y)-14.17%
ROE(3y)-734.11%
ROE(5y)-517.7%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -500 -1K -1.5K

1.3 Margins

  • RBLX has a Gross Margin of 78.07%. This is amongst the best in the industry. RBLX outperforms 87.34% of its industry peers.
  • RBLX's Gross Margin has been stable in the last couple of years.
  • RBLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.18%
GM growth 5Y1.07%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. RBLX Health Analysis

2.1 Basic Checks

  • RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • RBLX has more shares outstanding than it did 1 year ago.
  • RBLX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, RBLX has an improved debt to assets ratio.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • RBLX has an Altman-Z score of 1.41. This is a bad value and indicates that RBLX is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of RBLX (1.41) is comparable to the rest of the industry.
  • The Debt to FCF ratio of RBLX is 0.74, which is an excellent value as it means it would take RBLX, only 0.74 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.74, RBLX belongs to the best of the industry, outperforming 84.81% of the companies in the same industry.
  • RBLX has a Debt/Equity ratio of 2.55. This is a high value indicating a heavy dependency on external financing.
  • RBLX has a worse Debt to Equity ratio (2.55) than 74.68% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for RBLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF 0.74
Altman-Z 1.41
ROIC/WACCN/A
WACC8.87%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • RBLX has a Current Ratio of 0.96. This is a bad value and indicates that RBLX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • RBLX has a Current ratio of 0.96. This is comparable to the rest of the industry: RBLX outperforms 43.04% of its industry peers.
  • RBLX has a Quick Ratio of 0.96. This is a bad value and indicates that RBLX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • RBLX has a Quick ratio (0.96) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.96
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. RBLX Growth Analysis

3.1 Past

  • The earnings per share for RBLX have decreased strongly by -16.03% in the last year.
  • The Revenue has grown by 35.77% in the past year. This is a very strong growth!
  • The Revenue has been growing by 39.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.38%
Revenue 1Y (TTM)35.77%
Revenue growth 3Y30.02%
Revenue growth 5Y39.56%
Sales Q2Q%43.45%

3.2 Future

  • RBLX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.69% yearly.
  • RBLX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.76% yearly.
EPS Next Y-5.63%
EPS Next 2Y10.4%
EPS Next 3Y21.69%
EPS Next 5YN/A
Revenue Next Year24.4%
Revenue Next 2Y22.05%
Revenue Next 3Y21.04%
Revenue Next 5Y18.76%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. RBLX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RBLX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, RBLX is valued a bit cheaper than 78.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.64
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • RBLX's earnings are expected to grow with 21.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.4%
EPS Next 3Y21.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RBLX Dividend Analysis

5.1 Amount

  • RBLX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RBLX Fundamentals: All Metrics, Ratios and Statistics

ROBLOX CORP -CLASS A

NYSE:RBLX (5/1/2026, 8:04:00 PM)

After market: 45.21 +0.08 (+0.18%)

45.13

-10.13 (-18.33%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Industry Strength9.94
Industry Growth72.05
Earnings (Last)04-30
Earnings (Next)07-29
Inst Owners80.03%
Inst Owner Change-0.59%
Ins Owners4.42%
Ins Owner Change1.65%
Market Cap31.98B
Revenue(TTM)4.89B
Net Income(TTM)-1.07B
Analysts78.64
Price Target101.66 (125.26%)
Short Float %3.11%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.09%
Min EPS beat(2)7.91%
Max EPS beat(2)26.26%
EPS beat(4)3
Avg EPS beat(4)11.63%
Min EPS beat(4)-9.21%
Max EPS beat(4)26.26%
EPS beat(8)7
Avg EPS beat(8)16.06%
EPS beat(12)9
Avg EPS beat(12)11.73%
EPS beat(16)10
Avg EPS beat(16)2.75%
Revenue beat(2)2
Avg Revenue beat(2)10.33%
Min Revenue beat(2)6.33%
Max Revenue beat(2)14.32%
Revenue beat(4)4
Avg Revenue beat(4)9.34%
Min Revenue beat(4)3.4%
Max Revenue beat(4)14.32%
Revenue beat(8)6
Avg Revenue beat(8)5.66%
Revenue beat(12)7
Avg Revenue beat(12)3.65%
Revenue beat(16)7
Avg Revenue beat(16)-2.89%
PT rev (1m)-6.19%
PT rev (3m)-27.14%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-22.37%
EPS NY rev (1m)0.45%
EPS NY rev (3m)-6.89%
Revenue NQ rev (1m)-1.58%
Revenue NQ rev (3m)1.46%
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)3.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.54
P/FCF 23.64
P/OCF 17.8
P/B 81.08
P/tB 136.9
EV/EBITDA N/A
EPS(TTM)-1.52
EYN/A
EPS(NY)-1.21
Fwd EYN/A
FCF(TTM)1.91
FCFY4.23%
OCF(TTM)2.53
OCFY5.62%
SpS6.9
BVpS0.56
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -11.14%
ROE -269.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.07%
FCFM 27.66%
ROA(3y)-14.29%
ROA(5y)-14.17%
ROE(3y)-734.11%
ROE(5y)-517.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.18%
GM growth 5Y1.07%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF 0.74
Debt/EBITDA N/A
Cap/Depr 196.39%
Cap/Sales 9.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.96
Altman-Z 1.41
F-Score6
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)145.63%
Cap/Depr(5y)179.87%
Cap/Sales(3y)8.68%
Cap/Sales(5y)10.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.38%
EPS Next Y-5.63%
EPS Next 2Y10.4%
EPS Next 3Y21.69%
EPS Next 5YN/A
Revenue 1Y (TTM)35.77%
Revenue growth 3Y30.02%
Revenue growth 5Y39.56%
Sales Q2Q%43.45%
Revenue Next Year24.4%
Revenue Next 2Y22.05%
Revenue Next 3Y21.04%
Revenue Next 5Y18.76%
EBIT growth 1Y-15.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.96%
EBIT Next 3Y68.45%
EBIT Next 5Y43.89%
FCF growth 1Y110.96%
FCF growth 3YN/A
FCF growth 5Y26.89%
OCF growth 1Y118.45%
OCF growth 3Y69.44%
OCF growth 5Y27.93%

ROBLOX CORP -CLASS A / RBLX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ROBLOX CORP -CLASS A?

ChartMill assigns a fundamental rating of 3 / 10 to RBLX.


Can you provide the valuation status for ROBLOX CORP -CLASS A?

ChartMill assigns a valuation rating of 2 / 10 to ROBLOX CORP -CLASS A (RBLX). This can be considered as Overvalued.


Can you provide the profitability details for ROBLOX CORP -CLASS A?

ROBLOX CORP -CLASS A (RBLX) has a profitability rating of 2 / 10.


How financially healthy is ROBLOX CORP -CLASS A?

The financial health rating of ROBLOX CORP -CLASS A (RBLX) is 4 / 10.